Avanos Medical (AVNS) Other Operating Expenses (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Other Operating Expenses data on file, last reported at -$2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 250.0% year-over-year to -$2.4 million; the trailing twelve-month figure through Mar 2026 stood at -$3.6 million (down 163.16% YoY), and the FY2025 full-year result was $400000.0, down 89.74% from the prior year.
• Other Operating Expenses fell to -$2.4 million in Q1 2026, from $1.4 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $5.6 million in Q4 2024 to a low of -$9.5 million in Q3 2023.
• A 5-year average of -$858823.5 and a median of -$400000.0 in 2022 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses sank 2000.0% in 2024 and surged 900.0% in 2025, its largest moves.
• Tracing AVNS's Other Operating Expenses over 5 years: stood at -$400000.0 in 2022, then plunged by 525.0% to -$2.5 million in 2023, then surged by 324.0% to $5.6 million in 2024, then tumbled by 75.0% to $1.4 million in 2025, then slumped by 271.43% to -$2.4 million in 2026.
• Business Quant data shows AVNS's Other Operating Expenses at -$2.4 million in Q1 2026, $1.4 million in Q4 2025, and -$2.3 million in Q3 2025.